Ketogenic diet as a complementary therapy for myasthenia gravis - a randomized controlled trial
- Conditions
- G70.0Myasthenia gravis
- Registration Number
- DRKS00032686
- Lead Sponsor
- Charité - Universitätsmedizin Berlin
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 84
Patient capable of giving consent
- Diagnosis of myasthenia gravis
- Written consent to participate
- Body mass index 19-45 kg/m2
- Age 18-65 years
- Stable immunomodulatory therapy or no immunomodulatory therapy > 3 months prior to study entry
- Clinically relevant underlying metabolic or malignant disease
- Insulin-dependent diabetes mellitus type I
- Participation in another intervention study
- Eating disorder
- Kidney stones
- Therapy with oral anticoagulants
- Pregnancy or breastfeeding
- Assumed lack of compliance
- Known alcohol or drug abuse
- anticoagulant medication
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.